EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial peptides and other potential biomarkers of critical illness in SARS‐CoV‐2 patients with acute kidney injury. AMPAKI‐CoV study

Lucas Ferreira Theotonio Dos Santos iD, Hermes Vieira Barbeiro, Denise Frediani Barbeiro, Heraldo Possolo de Souza, Fabiano Pinheiro da Silva

Physiological Reports · 2024

DOI: 10.14814/phy2.15945 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Physiological Reports, 2024. Verfasst von Lucas Ferreira Theotonio Dos Santos und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Emergências Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brasil. Hauptthemen laut MEDLINE: beta-Defensins, alpha-Defensins, COVID-19, Acute Kidney Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial peptides (AMPs) constitute a complex network of 10–100 amino acid sequence molecules widely distributed in nature. While over 300 AMPs have been described in mammals, cathelicidins and defensins remain the most extensively studied. Some publications have explored the role of AMPs in COVID‐19, but these findings are preliminary, and in vivo studies are still lacking. In this study, we report the plasma levels of five AMPs (LL‐37, α‐defensin 1, α‐defensin 3, β‐defensin 1, and β‐defensin 3), using the ELISA technique (MyBioSource, San Diego, CA, United States, kits MBS2601339 (beta‐defensin 1), MBS2602513 (beta‐defensin 3), MBS703879 (alpha‐defensin 1), MBS706289 (alpha‐defensin 3), MBS7234921 (LL37)), and the measurement of six cytokines (tumor necrosis factor‐α, interleukin‐1β, interleukin‐6, interleukin‐10, interferon‐γ, and monocyte chemoattractant protein‐1), through the magnetic bead immunoassay Milliplex® and the MAGPIX® System (MilliporeSigma, Darmstadt, Germany, kit HCYTOMAG‐60 K (cytokines)), in 15 healthy volunteers, 36 COVID‐19 patients without Acute Kidney Injury (AKI) and 17 COVID‐19 patients with AKI. We found increased levels of α‐defensin 1, α‐defensin 3 and β‐defensin 3, in our COVID‐19 population, when compared to healthy controls, along with higher levels of interleukin‐6, interleukin‐10, interferon‐γ, and monocyte chemoattractant protein‐1. These findings suggest that these AMPs and cytokines may play a crucial role in the systemic inflammatory response and tissue damage characterizing severe COVID‐19. The levels of α‐defensin 1 and α‐defensin 3 were significantly higher in COVID‐19 AKI group in comparison to the non‐AKI group. Furthermore, IL‐10 and the product IL‐10 × IL‐1B showed excellent performance in discriminating AKI, with AUCs of 0.86 and 0.88, respectively. Among patients with COVID‐19, AMPs may play a key role in the inflammation process and disease progression. Additionally, α‐defensin 1 and α‐defensin 3 may mediate the AKI process in these patients, representing an opportunity for further research and potential therapeutic alternatives in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-Defensinsalpha-DefensinsCOVID-19Acute Kidney InjuryAnimalsHumansInterleukin-10Antimicrobial Cationic PeptidesChemokine CCL2SARS-CoV-2Antimicrobial PeptidesInterleukin-6Interferon-gammaCritical IllnessCytokinesBiomarkersMammals

Stichwörter der Autor:innen

COVID-19Interleukin-10acute kidney injurycathelicidinsdefensinsinnate immunity

Substanzen

beta-DefensinsInterleukin-10Antimicrobial Cationic PeptidesChemokine CCL2Antimicrobial PeptidesInterleukin-6alpha-DefensinsInterferon-gammaCytokinesBiomarkers

Autor:innen und Institutionen

  • Laboratório de Emergências Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brasil.

ORCID-Profile: Lucas Ferreira Theotonio Dos Santos

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Zitieren

APA

Theotonio Dos Santos, L. F., Barbeiro, H. V., Barbeiro, D. F., de Souza, H. P., & Pinheiro da Silva, F. (2024). Antimicrobial peptides and other potential biomarkers of critical illness in SARS‐CoV‐2 patients with acute kidney injury. AMPAKI‐CoV study. Physiological Reports. https://doi.org/10.14814/phy2.15945

Vancouver

Theotonio Dos Santos LF, Barbeiro HV, Barbeiro DF, de Souza HP, Pinheiro da Silva F. Antimicrobial peptides and other potential biomarkers of critical illness in SARS‐CoV‐2 patients with acute kidney injury. AMPAKI‐CoV study. Physiological Reports. 2024. doi:10.14814/phy2.15945

BibTeX
@article{TheotonioDosSantos2024,
  author = {Theotonio Dos Santos, Lucas Ferreira and Barbeiro, Hermes Vieira and Barbeiro, Denise Frediani and de Souza, Heraldo Possolo and Pinheiro da Silva, Fabiano},
  title = {Antimicrobial peptides and other potential biomarkers of critical illness in SARS‐CoV‐2 patients with acute kidney injury. AMPAKI‐CoV study},
  journal = {Physiological Reports},
  year = {2024},
  doi = {10.14814/phy2.15945}
}
Kostenlos starten →